Neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screening

Abstract To evaluate the neuropharmacological profile of new spiro thiazepinone and thiazolidinone compounds in CD1 mice after a computer-aided virtual screening based on a GABA-A/BZD site. From a library of 240 pyrazolo[1,4]thiazepin-3-ones and 39 pyrimidinyl thiazolidin-4-ones, two molecular proto...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Sebastian Carrero-Sandoval, Paola Andrea Cuervo-Prado, Fabian Orozco-Lopez, Christian Alonso Becerra-Rivas, Estefany Arias-Quiroz, Mario Francisco Guerrero-Pabón
Format: Article
Language:English
Published: Universidade de São Paulo 2025-01-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100803&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592533903900672
author Juan Sebastian Carrero-Sandoval
Paola Andrea Cuervo-Prado
Fabian Orozco-Lopez
Christian Alonso Becerra-Rivas
Estefany Arias-Quiroz
Mario Francisco Guerrero-Pabón
author_facet Juan Sebastian Carrero-Sandoval
Paola Andrea Cuervo-Prado
Fabian Orozco-Lopez
Christian Alonso Becerra-Rivas
Estefany Arias-Quiroz
Mario Francisco Guerrero-Pabón
author_sort Juan Sebastian Carrero-Sandoval
collection DOAJ
description Abstract To evaluate the neuropharmacological profile of new spiro thiazepinone and thiazolidinone compounds in CD1 mice after a computer-aided virtual screening based on a GABA-A/BZD site. From a library of 240 pyrazolo[1,4]thiazepin-3-ones and 39 pyrimidinyl thiazolidin-4-ones, two molecular prototypes of each series were selected by virtual screening using the rank consensus molecular docking approach, based on the GABA-A/BZD site. These compounds, coded as cpTP-0, cpTP-1, TAP-2 and cpTAP-2, were synthesised by multicomponent reactions and evaluated by neuropharmacological screening in CD1 mice (100 mg/kg, p.o.). The study revealed that cpTAP-2 exhibited a significant reduction of immobility time during the forced swimming test (FST), while it did not show any major effects in the rota-rod, open field, plus maze, tail suspension, pentylenetetrazole seizures, and barbiturate sleeping time tests. In a dose-response evaluation, cpTAP-2 reduced immobility time during forced swimming test in CD1 male mice at doses of 100 and 300 mg/kg with biologically relevant effect sizes. These results suggest that cpTAP-2 could elicit antidepressant effects possibly related to GABA-A/benzodiazepine site, although other mechanisms could be implicated.
format Article
id doaj-art-d40e2397413f4cd1ad1b5132507e7783
institution Kabale University
issn 2175-9790
language English
publishDate 2025-01-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj-art-d40e2397413f4cd1ad1b5132507e77832025-01-21T07:42:21ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902025-01-016110.1590/s2175-97902025e24066Neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screeningJuan Sebastian Carrero-Sandovalhttps://orcid.org/0009-0006-5516-7029Paola Andrea Cuervo-Pradohttps://orcid.org/0000-0003-4957-2811Fabian Orozco-Lopezhttps://orcid.org/0000-0003-4553-9985Christian Alonso Becerra-Rivashttps://orcid.org/0000-0002-9662-3813Estefany Arias-Quirozhttps://orcid.org/0009-0006-9530-4913Mario Francisco Guerrero-Pabónhttps://orcid.org/0000-0003-1789-1818Abstract To evaluate the neuropharmacological profile of new spiro thiazepinone and thiazolidinone compounds in CD1 mice after a computer-aided virtual screening based on a GABA-A/BZD site. From a library of 240 pyrazolo[1,4]thiazepin-3-ones and 39 pyrimidinyl thiazolidin-4-ones, two molecular prototypes of each series were selected by virtual screening using the rank consensus molecular docking approach, based on the GABA-A/BZD site. These compounds, coded as cpTP-0, cpTP-1, TAP-2 and cpTAP-2, were synthesised by multicomponent reactions and evaluated by neuropharmacological screening in CD1 mice (100 mg/kg, p.o.). The study revealed that cpTAP-2 exhibited a significant reduction of immobility time during the forced swimming test (FST), while it did not show any major effects in the rota-rod, open field, plus maze, tail suspension, pentylenetetrazole seizures, and barbiturate sleeping time tests. In a dose-response evaluation, cpTAP-2 reduced immobility time during forced swimming test in CD1 male mice at doses of 100 and 300 mg/kg with biologically relevant effect sizes. These results suggest that cpTAP-2 could elicit antidepressant effects possibly related to GABA-A/benzodiazepine site, although other mechanisms could be implicated.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100803&lng=en&tlng=enAntidepressantDrug designVirtual screeningSpirothiazolidinoneGABA-A/BZD receptor
spellingShingle Juan Sebastian Carrero-Sandoval
Paola Andrea Cuervo-Prado
Fabian Orozco-Lopez
Christian Alonso Becerra-Rivas
Estefany Arias-Quiroz
Mario Francisco Guerrero-Pabón
Neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screening
Brazilian Journal of Pharmaceutical Sciences
Antidepressant
Drug design
Virtual screening
Spirothiazolidinone
GABA-A/BZD receptor
title Neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screening
title_full Neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screening
title_fullStr Neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screening
title_full_unstemmed Neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screening
title_short Neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screening
title_sort neuropharmacological profile of new thiazepinone and thiazolidinone compounds designed by virtual screening
topic Antidepressant
Drug design
Virtual screening
Spirothiazolidinone
GABA-A/BZD receptor
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100803&lng=en&tlng=en
work_keys_str_mv AT juansebastiancarrerosandoval neuropharmacologicalprofileofnewthiazepinoneandthiazolidinonecompoundsdesignedbyvirtualscreening
AT paolaandreacuervoprado neuropharmacologicalprofileofnewthiazepinoneandthiazolidinonecompoundsdesignedbyvirtualscreening
AT fabianorozcolopez neuropharmacologicalprofileofnewthiazepinoneandthiazolidinonecompoundsdesignedbyvirtualscreening
AT christianalonsobecerrarivas neuropharmacologicalprofileofnewthiazepinoneandthiazolidinonecompoundsdesignedbyvirtualscreening
AT estefanyariasquiroz neuropharmacologicalprofileofnewthiazepinoneandthiazolidinonecompoundsdesignedbyvirtualscreening
AT mariofranciscoguerreropabon neuropharmacologicalprofileofnewthiazepinoneandthiazolidinonecompoundsdesignedbyvirtualscreening